Related references
Note: Only part of the references are listed.Phenotypic and Genotypic Characterization of Enterobacteriaceae with Decreased Susceptibility to Carbapenems: Results from Large Hospital-Based Surveillance Studies in China
Qiwen Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Emergence of KPC-Producing Pseudomonas aeruginosa in the United States
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel
Azita Leavitt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Worldwide Experience with the Use of Doripenem against Extended-Spectrum-β-Lactamase-Producing and Ciprofloxacin-Resistant Enterobacteriaceae: Analysis of Six Phase 3 Clinical Studies
Kone Kaniga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
Alexandre P. Zavascki et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium
P. Bogaerts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
Federico Perez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
Regional Dissemination of KPC-Producing Klebsiella pneumoniae
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 beta-Lactamases
Daniel J. Wolter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)
Paul R. Rhomberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
Mariana Castanheira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Andrea Endimiani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
Michel Doumith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Effects of Efflux Pump Inhibitors Phenyl-Arginine-beta-Naphthylamide and 1-(1-Naphthylmethyl)-Piperazine on the Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
A. Y. Coban et al.
JOURNAL OF CHEMOTHERAPY (2009)
Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes
Justin M. Cole et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States
Chris M. Pillar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Correlation of antimicrobial resistance with β-lactamases, the OmpA-Like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York city
Simona Bratu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance
Ronald N. Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem
Anna Farra et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing enterobactefiaceae:: Report from the SENTRY antimicrobial surveillance program
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake
Maria A. Mussi et al.
FEBS LETTERS (2007)
Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006)
Paul R. Rhomberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
An increasing threat in hospitals:: multidrug-resistant Acinetobacter baumannii
Lenie Dijkshoorn et al.
NATURE REVIEWS MICROBIOLOGY (2007)
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii
Wensi S. Hu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa
Narcisa Mesaros et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis
Rodrigo E. Mendes et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Jordi Vila et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005)
Lalitagauri M. Deshpande et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2006)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
JF Turton et al.
FEMS MICROBIOLOGY LETTERS (2006)
Multidrug efflux inhibition in Acinetobacter baumannii:: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide
S Pannek et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
CTX-M-15 extended-spectrum beta-lactamase from Nigerian Klebsiella pneumoniae
OO Soge et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L. Poirel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Identification of an OprD homologue in Acinetobacter baumannii
M Dupont et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection
S Bratu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii
PG Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Outbreak of Klebsiella pneumoniae producing a new carbapenern hydrolyzing class a β-lactamase, KPC-3, in a New York Medical Center
N Woodford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City
J Quale et al.
CLINICAL INFECTIOUS DISEASES (2003)
Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii
F Fernández-Cuenca et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454
S Magnet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Of Pseudomonas, porins, pumps and carbapenems
DM Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates
H Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii
G Bou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)